Clinical Trials Browser

OTHER × Gastrointestinal Neoplasms × regorafenib × Clear all

NCT02386397 2026-03-12

BREGO

Phase 1/2 Completed

Gastrointestinal

Gastrointestinal Neoplasms

NCT02241720 2018-01-11

Regorafenib Second Line Treatment of Metastatic or Advanced Upper GI Cancers

Phase 2 Terminated

5 enrolled 6 charts

Gastrointestinal

Gastrointestinal Neoplasms